Supernova Research
Investment Thesis
Supernova (The Supernova Fund) is a Miami-based venture firm built around a single idea: capital alone doesn't compound, judgment does. Rather than raising a fund first and figuring out value-add later, co-founders Christopher Staley and Barry Stamos spent 2021-2025 building and proving an operating model before ever taking an LP dollar. The model: a network of 250-350+ exited founders is matched systematically (via a proprietary system called NOVA AI) to portfolio companies at the highest-leverage decision points, and those exited founders are embedded as operators - not passive board members - alongside capital. The fund formalized in 2025 once the pre-fund track record (highlighted by Colossal Biosciences reaching decacorn status) was established.
Sector Focus
Supernova organizes its thesis around five "forces": (1) Human Capability & Healthspan - companies that preserve energy, clarity, mobility, and resilience rather than just treating sickness (comps cited: Livongo, Dexcom, Calm, Headspace); (2) Trust Infrastructure for Money, Data & Commerce - identity, compliance, payments, and data platforms that reduce friction (comps: Stripe, Adyen, Plaid, Square); (3) Sustainability & Regeneration - traceability, cleaner inputs, and regenerative supply chains as a business model, not a premium; (4) Energy & Infrastructure as Strategic Capacity - grid, compute, and electrification bottlenecks; (5) Consumer & Food Brands - tech-enabled brands that compound through repeat purchase and distribution.
Stage Focus
Primary focus is Seed and Series A, with the platform also backing growth-stage companies in the $5M-$30M+ ARR range where an embedded exited founder can accelerate a specific inflection point (revenue growth, AI transformation, executive hiring, market expansion, distribution, M&A, capital raising, or exit readiness).
Check Size
Supernova invests up to roughly $2M+ per company, across up to 12 companies at a time, always paired with an embedded exited-founder "tiger team" rather than as a pure capital check.
Lead Tendency
Not clearly stated on the public site; the model is built around co-investing and embedding operators alongside a company's existing cap table rather than explicitly leading or pricing rounds, so this is marked unknown pending direct confirmation.
Recent Activity
The fund itself formalized in 2025 after years of pre-fund operation. Its highest-profile portfolio company, Colossal Biosciences (de-extinction/biotech, activated with founder Ben Lamm in 2022), raised a $200M Series C in January 2025 at a $10.2B valuation (making it the first Texas decacorn), then raised an additional $120M extension in September 2025 for its dodo de-extinction program.
Portfolio Highlights
Colossal Biosciences is the flagship proof point ($10B+ valuation, decacorn in under 4 years). The broader portfolio spans health/wellness (Apollo Neuro, Brain Ritual, Healthy Young Minds, Myndbend), fintech (Baubap), care/marketplace platforms (AyaCare, Clinicom, Gravy Work), consumer/CPG (Vegetable and Butcher, SoulSpring), and AI/productivity tools (Attention Hero, EchoTwin, Humantelligence, LiquiView).
Team
- Christopher Staley, Managing Partner: Founding Partner at Fuel VC ($225M) and Rokk3r Labs; Founding Partner of Opopop (Series B) with Jonas Temple, co-founder of Beats by Dre.
- Barry Stamos, General Partner: 3x exited founder with exits to Oracle ($1.6B) and IPG ($2.3B); former EIR at 500 Global; has raised $125M+ for startups through investor relations.
- Matti Anttila, General Partner: 2x exited founder, 20+ years in consumer/CPG; CEO of Grain & Barrel Spirits (Inc. 5000); former investment banker at J.P. Morgan.
- Tim Chang, Venture Partner: 2x Midas List; Founding Partner at Mayfield; led investments in MOAT (acquired by Oracle), Basis (acquired by Intel), and Grove Collaborative (NYSE); 20x board director.
- Paul Eskenazi, Operating Partner: Former CFO at Beats by Dre; board experience at Hyperice, Blue Microphones (Logitech), and Alpha Foods; CFO of The Jim Henson Company.
- Daniel Dubois, Venture Partner: 2x exited founder; B7 and G20 delegate; Partner at Side Door Ventures ($100M) and Gaingels ($800M+ deployed); founded EO and YPO Angels.
Decision Process
Multiple General Partners and Venture/Operating Partners suggest a partnership-style decision process rather than a solo GP.
Founder Preferences
Supernova explicitly backs "conscious founders" building in its five focus themes, and frames itself as an operator-partner rather than a passive investor: it looks for founders willing to bring in an embedded exited founder at a critical inflection point rather than treat capital as the whole relationship.
Geographic Focus
Headquartered in the Miami-Fort Lauderdale area, with local ecosystem ties to Endeavor Miami and eMerge Americas; portfolio companies are not geographically restricted to South Florida.